Follow
Karel Soucek
Karel Soucek
Institute of Biophysics AS CR
Verified email at ibp.cz
Title
Cited by
Cited by
Year
Alternative mechanisms of miR-34a regulation in cancer
E Slabáková, Z Culig, J Remšík, K Souček
Cell death & disease 8 (10), e3100-e3100, 2017
2522017
Exacerbation of substrate toxicity by IPTG in Escherichia coli BL21(DE3) carrying a synthetic metabolic pathway
P Dvorak, L Chrast, PI Nikel, R Fedr, K Soucek, M Sedlackova, ...
Microbial cell factories 14, 1-15, 2015
2382015
ZEB1: a critical regulator of cell plasticity, DNA damage response, and therapy resistance
S Drápela, J Bouchal, MK Jolly, Z Culig, K Souček
Frontiers in molecular biosciences 7, 36, 2020
1192020
TGF‐β1‐induced EMT of non‐transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug
E Slabáková, Z Pernicová, E Slavíčková, A Staršíchová, A Kozubík, ...
The prostate 71 (12), 1332-1343, 2011
1072011
The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques
L Vistejnova, J Dvorakova, M Hasova, T Muthny, V Velebny, K Soucek, ...
Neuroendocrinology Letters 30 (1), 121, 2009
1032009
Normal and prostate cancer cells display distinct molecular profiles of α‐tubulin posttranslational modifications
K Souček, A Kamaid, AD Phung, L Kubala, JC Bulinski, RW Harper, ...
The Prostate 66 (9), 954-965, 2006
1012006
Growth/differentiation factor-15: prostate cancer suppressor or promoter?
P Vaňhara, A Hampl, A Kozubík, K Souček
Prostate cancer and prostatic diseases 15 (4), 320-328, 2012
852012
High effectiveness of platinum (IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro
A Kozubík, V Horváth, L Švihálková-Šindlerová, K Souček, J Hofmanová, ...
Biochemical pharmacology 69 (3), 373-383, 2005
832005
The fibroblast surface markers FAP, anti‐fibroblast, and FSP are expressed by cells of epithelial origin and may be altered during epithelial‐to‐mesenchymal transition
Z Kahounová, D Kurfürstová, J Bouchal, G Kharaishvili, J Navrátil, ...
Cytometry Part A 93 (9), 941-951, 2018
772018
Inhibition of topoisomerase IIα: novel function of wedelolactone
P Benes, L Knopfova, F Trcka, A Nemajerova, D Pinheiro, K Soucek, ...
Cancer letters 303 (1), 29-38, 2011
762011
Trop2: Jack of all trades, master of none
S Lenárt, P Lenárt, J Šmarda, J Remšík, K Souček, P Beneš
Cancers 12 (11), 3328, 2020
752020
Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells
R Jendželovský, J Mikeš, K Souček, J Procházková, M Kello, V Sačková, ...
Photochemical & Photobiological Sciences 8 (12), 1716-1723, 2009
732009
c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis
L Knopfová, P Beneš, L Pekarčíková, M Hermanová, M Masařík, ...
Molecular cancer 11, 1-15, 2012
702012
Rottlerin Inhibits ROS Formation and Prevents NFκB Activation in MCF‐7 and HT‐29 Cells
E Maioli, L Greci, K Soucek, M Hyzdalova, A Pecorelli, V Fortino, ...
BioMed Research International 2009 (1), 742936, 2009
672009
Effect of apple extracts on NF-κB activation in human umbilical vein endothelial cells
PA Davis, JA Polagruto, G Valacchi, A Phung, K Soucek, CL Keen, ...
Experimental Biology and Medicine 231 (5), 594-598, 2006
632006
T umor suppressor candidate 3 (TUSC3) prevents the epithelial‐to‐mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in …
K Kratochvílová, P Horak, M Ešner, K Souček, D Pils, M Anees, ...
International journal of cancer 137 (6), 1330-1340, 2015
562015
Gene expression changes in human prostate carcinoma cells exposed to genotoxic and nongenotoxic aryl hydrocarbon receptor ligands
E Hrubá, J Vondráček, H Líbalová, J Topinka, V Bryja, K Souček, ...
Toxicology letters 206 (2), 178-188, 2011
562011
Growth/differentiation factor-15 inhibits differentiation into osteoclasts—A novel factor involved in control of osteoclast differentiation
P Vaňhara, E Lincová, A Kozubík, P Jurdic, K Souček, J Šmarda
Differentiation 78 (4), 213-222, 2009
522009
Rottlerin inhibits the nuclear factor κB/Cyclin-D1 cascade in MCF-7 breast cancer cells
C Torricelli, V Fortino, E Capurro, G Valacchi, A Pacini, M Muscettola, ...
Life sciences 82 (11-12), 638-643, 2008
512008
Different modulation of TRAIL-induced apoptosis by inhibition of pro-survival pathways in TRAIL-sensitive and TRAIL-resistant colon cancer cells
A Vaculová, J Hofmanová, K Souček, A Kozubík
FEBS letters 580 (28-29), 6565-6569, 2006
512006
The system can't perform the operation now. Try again later.
Articles 1–20